BMJ  2005;330:389 (19 February), doi:10.1136/bmj.330.7488.389

Paper

Antidepressant treatment and the risk of fatal and non-fatal self harm in first episode depression: nested case-control study

¹ General Practice Research Database Division, Medicines and Healthcare products Regulatory Agency, London SW8 5NQ, ² Post-Licensing Division, Medicine and Healthcare products Regulatory Agency, ³ Wolfson Institute of Preventive Medicine, Queen Mary, University of London, ⁴ Department of Psychiatry, University of Edinburgh, Edinburgh, ⁵ Medical Statistics Unit, London School of Hygiene and Tropical Medicine, London, ⁶ Department of Social Medicine, University of Bristol, Bristol BS8 2PR

Objective To compare the risk of non-fatal self harm and suicide in patients taking selective serotonin reuptake inhibitors (SSRIs) with that of patients taking tricyclic antidepressants, as well as between different SSRIs and different tricyclic antidepressants.

Design Nested case-control study.

Setting Primary care in the United Kingdom.

Participants 146 095 individuals with a first prescription of an antidepressant for depression.

Main outcome measures Suicide and non-fatal self harm.

Results 1968 cases of non-fatal self harm and 69 suicides occurred. The overall adjusted odds ratio of non-fatal self harm was 0.99 (95% confidence interval 0.86 to 1.14) and that of suicide 0.57 (0.26 to 1.25) in people prescribed SSRIs compared with those prescribed tricyclic antidepressants. We found little evidence that associations differed over time since starting or stopping treatment. We found some evidence that risks of non-fatal self harm in people prescribed SSRIs compared with those prescribed tricyclic antidepressants differed by age group (interaction P = 0.02). The adjusted odds ratio of non-fatal self harm for people prescribed SSRIs compared with users of tricylic antidepressants for those aged 18 or younger was 1.59 (1.01 to 2.50), but no association was apparent in other age groups. No suicides occurred in those aged 18 or younger currently or recently prescribed tricyclic antidepressants or SSRIs.

Conclusion We found no evidence that the risk of suicide or non-fatal self harm in adults prescribed SSRIs was greater than in those prescribed tricyclic antidepressants. We found some weak evidence of an increased risk of non-fatal self harm for current SSRI use among those aged 18 or younger. However, preferential prescribing of SSRIs to patients at higher risk of suicidal behaviour cannot be ruled out.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Relevant Articles

Risk of suicide during treatment with venlafaxine, citalopram, fluoxetine, and dothiepin: retrospective cohort study

Annalisa Rubino, Neil Roskell, Pat Tennis, Daniel Mines, Scott Weich, and Elizabeth Andrews
BMJ 2007 334: 242. [Abstract] [Full Text] [PDF]

Do selective serotonin reuptake inhibitors cause suicide?: Risk of suicide should be assessed for whole class of antidepressants

François Curtin and Pierre Schulz
BMJ 2005 330: 1148. [Extract] [Full Text] [PDF]

Do selective serotonin reuptake inhibitors cause suicide?: Authors' reply to Curtin and Schulz, and Healy

David Gunnell, Julia Saperia, and Deborah Ashby
BMJ 2005 330: 1148-1149. [Extract] [Full Text]

Regulator restricts use of SSRIs in children

Lynn Eaton
BMJ 2005 330: 984. [Extract] [Full Text]

SSRIs and suicide: risks seem to be similar to risks with tricyclics
BMJ 2005 330: 0. [Full Text]

Pills, thrills, and bellyaches

Kamran Abbasi
BMJ 2005 330: 0. [Extract] [Full Text] [PDF]

Suicide, depression, and antidepressants

Andrea Cipriani, Corrado Barbui, and John R Geddes
BMJ 2005 330: 373-374. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

• Barbui, C. MD, Esposito, E. MD, Cipriani, A. MD (2009). Selective serotonin reuptake inhibitors and risk of suicide: a systematic review of observational studies. CMAJ 180: 291-297 [Abstract] [Full text]  
• Qaseem, A., Snow, V., Denberg, T. D., Forciea, M. A., Owens, D. K., for the Clinical Efficacy Assessment Subcommittee, (2008). Using Second-Generation Antidepressants to Treat Depressive Disorders: A Clinical Practice Guideline from the American College of Physicians. ANN INTERN MED 149: 725-733 [Abstract] [Full text]  
• Gartlehner, G., Gaynes, B. N., Hansen, R. A., Thieda, P., DeVeaugh-Geiss, A., Krebs, E. E., Moore, C. G., Morgan, L., Lohr, K. N. (2008). Comparative Benefits and Harms of Second-Generation Antidepressants: Background Paper for the American College of Physicians. ANN INTERN MED 149: 734-750 [Abstract] [Full text]  
• Anderson, I., Ferrier, I., Baldwin, R., Cowen, P., Howard, L, Lewis, G, Matthews, K, McAllister-Williams, R., Peveler, R., Scott, J, Tylee, A (2008). Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2000 British Association for Psychopharmacology guidelines. J Psychopharmacol 22: 343-396 [Abstract]  
• (2008). Bibliography for Major Depressive Disorder and Suicide. Focus 6: 58-62 [Full text]  
• Cheung, A. H., Zuckerbrot, R. A., Jensen, P. S., Ghalib, K., Laraque, D., Stein, R. E.K., and the GLAD-PC Steering Group, (2007). Guidelines for Adolescent Depression in Primary Care (GLAD-PC): II. Treatment and Ongoing Management. Pediatrics 120: e1313-e1326 [Abstract] [Full text]  
• Pitman, A. (2007). Policy on the prevention of suicidal behaviour; one treatment for all may be an unrealistic expectation. JRSM 100: 461-464 [Abstract] [Full text]  
• Gibbons, R. D., Brown, C. H., Hur, K., Marcus, S. M., Bhaumik, D. K., Mann, J. J. (2007). Relationship Between Antidepressants and Suicide Attempts: An Analysis of the Veterans Health Administration Data Sets. Am. J. Psychiatry 164: 1044-1049 [Abstract] [Full text]  
• Cipriani, A., Geddes, J. R, Barbui, C. (2007). Venlafaxine for major depression. BMJ 334: 215-216 [Full text]  
• Rubino, A., Roskell, N., Tennis, P., Mines, D., Weich, S., Andrews, E. (2007). Risk of suicide during treatment with venlafaxine, citalopram, fluoxetine, and dothiepin: retrospective cohort study. BMJ 334: 242-242 [Abstract] [Full text]  
• Fischer, M. A., Servi, A. D., Polinski, J. M., Wang, P. S. (2007). Restrictions on Antidepressant Medications for Children: A Review of Medicaid Policy. Psychiatr. Serv. 58: 135-138 [Abstract] [Full text]  
• Tiihonen, J., Lonnqvist, J., Wahlbeck, K., Klaukka, T., Tanskanen, A., Haukka, J. (2006). Antidepressants and the Risk of Suicide, Attempted Suicide, and Overall Mortality in a Nationwide Cohort. Arch Gen Psychiatry 63: 1358-1367 [Abstract] [Full text]  
• Ebmeier, K. P (2006). No apparent difference in suicide risk between older and newer antidepressants although older drugs may increase risk of suicide attempt during the first month of treatment.. Evid. Based Ment. Health 9: 82-82 [Full text]  
• Olfson, M., Marcus, S. C., Shaffer, D. (2006). Antidepressant drug therapy and suicide in severely depressed children and adults: a case-control study.. Arch Gen Psychiatry 63: 865-872 [Abstract] [Full text]  
• McHenry, L (2006). Ethical issues in psychopharmacology.. J. Med. Ethics 32: 405-410 [Abstract] [Full text]  
• Juurlink, D. N., Mamdani, M. M., Kopp, A., Redelmeier, D. A. (2006). The Risk of Suicide With Selective Serotonin Reuptake Inhibitors in the Elderly. Am. J. Psychiatry 163: 813-821 [Abstract] [Full text]  
• RESELAND, S., BRAY, I., GUNNELL, D. (2006). Relationship between antidepressant sales and secular trends in suicide rates in the Nordic countries. Br. J. Psychiatry 188: 354-358 [Abstract] [Full text]  
• Baldessarini, R. J., Pompili, M., Tondo, L. (2006). Suicidal risk in antidepressant drug trials.. Arch Gen Psychiatry 63: 246-248 [Full text]  
• Hansen, R. A., Gartlehner, G., Lohr, K. N., Gaynes, B. N., Carey, T. S. (2005). Efficacy and Safety of Second-Generation Antidepressants in the Treatment of Major Depressive Disorder. ANN INTERN MED 143: 415-426 [Abstract] [Full text]  
• Leslie, L. K., Newman, T. B., Chesney, P. J., Perrin, J. M. (2005). The Food and Drug Administration's Deliberations on Antidepressant Use in Pediatric Patients. Pediatrics 116: 195-204 [Abstract] [Full text]  
• Chou, R., Helfand, M. (2005). Challenges in Systematic Reviews That Assess Treatment Harms. ANN INTERN MED 142: 1090-1099 [Abstract] [Full text]  
• Curtin, F., Schulz, P. (2005). Do selective serotonin reuptake inhibitors cause suicide?: Risk of suicide should be assessed for whole class of antidepressants. BMJ 330: 1148-1148 [Full text]  
• Gunnell, D., Saperia, J., Ashby, D. (2005). Do selective serotonin reuptake inhibitors cause suicide?: Authors' reply to Curtin and Schulz, and Healy. BMJ 330: 1148-1149 [Full text]  
• Eaton, L. (2005). Regulator restricts use of SSRIs in children. BMJ 330: 984- [Full text]  
• (2005). Do SSRIs Increase Suicide Risk in Adults?. Journal Watch Dermatology 2005: 10-10 [Full text]  
• (2005). Antidepressants, Adults, and Suicidality. JWatch Women's Health 2005: 7-7 [Full text]  
• (2005). Do SSRIs Increase Suicide Risk in Adults?. JWatch General 2005: 6-6 [Full text]  
• (2005). SSRIs and Suicide Risk: A Concern for Adults, Too?. JWatch Psychiatry 2005: 1-1 [Full text]  
• Cipriani, A., Barbui, C., Geddes, J. R (2005). Suicide, depression, and antidepressants. BMJ 330: 373-374 [Full text]  

Online poll

Find out more >>